Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Mark Brincat joins Exco InTouch to lead its mHealth strategy

Brincat was the pharma company's former European healthcare informatics director

Mark Brincat has been appointed product development director at Exco InTouch, a Nottingham, UK-based firm that provides interactive mobile patient communication tools for clinical trials.

He joins the company from Pfizer where he where he spent the last thirteen years managing the delivery of emerging and innovative business technology at Pfizer.

Most recently Brincat served as the pharma company's European healthcare informatics director, working across clinical trials, drug compliance, disease management and 'wellness'.

He also managed the first ever remote patient clinical trial, working with Exco and its mobile diary technology.

In his new role at Exco InTouch Brincat will lead mHealth and mobile product strategy with a particular focus on developing targeted tools for specific therapy areas.

He said: "We all know that healthcare is at a crossroads, so there is no better time to be working with pharmaceutical and healthcare providers to deliver effective and innovative new mHealth solutions directly to patients.”

30th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

brian smith science of the deal
The science of the deal
Business development is more like child-raising than you might think...
The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...

Infographics